In last trading session, Klotho Neurosciences Inc (NASDAQ:KLTO) saw 3.32 million shares changing hands with its beta currently measuring 2.56. Company’s recent per share price level of $1.36 trading at $0.08 or 6.25% at ring of the bell on the day assigns it a market valuation of $71.68M. That closing price of KLTO’s stock is at a discount of -187.5% from its 52-week high price of $3.91 and is indicating a premium of 91.91% from its 52-week low price of $0.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 24.2 million shares which gives us an average trading volume of 43.83 million if we extend that period to 3-months.

Klotho Neurosciences Inc (NASDAQ:KLTO) trade information

Klotho Neurosciences Inc’s shares saw a change of -17.07% in year-to-date performance and have moved -6.85% in past 5-day. Klotho Neurosciences Inc (NASDAQ:KLTO) showed a performance of -18.07% in past 30-days. Number of shares sold short was 2.67 million shares which calculate 0.05 days to cover the short interests.

Klotho Neurosciences Inc (NASDAQ:KLTO)’s Major holders

Insiders are in possession of 50.23% of company’s total shares while institution are holding 2.60 percent of that, with stock having share float percentage of 5.23%. Investors also watch the number of corporate investors in a company very closely, which is 2.60% institutions for Klotho Neurosciences Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 90.06 shares of worth $0.12 million or 0.17% of the total outstanding shares. The later fund manager was in possession of 21.4 shares on May 31, 2025 , making its stake of worth around $29102.0 in the company or a holder of 0.04% of company’s stock.